NRC Health - Common Stock (NRC)
Industrials › Services-Commercial Physical & Biological Research
Price History
Feb 9, 2026 — May 12, 2026Investment Snapshot
- Trading 580% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 4/9 — moderate financial health
- ROE of 94.0% — good return on equity
- Dividend yield of 2.8%
NRC Health - Common Stock (NRC) is a Industrials company operating in Services-Commercial Physical & Biological Research, listed on the NASDAQ , with a market capitalisation of $422 million . Key value metrics: P/E ratio 33.3, P/B ratio 31.25, Piotroski F-Score 4 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
NRC Health - Common Stock — Fundamental Analysis Summary
NRC Health - Common Stock (NRC) is currently trading 580% above its Graham Number of $2.75, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 33.3x.
On financial health, NRC shows a moderate Piotroski F-Score of 4/9, and strong return on equity of 94.0% (sector average: 4.9%), and high leverage with a debt-to-equity ratio of 5.48.
StockPik's composite Value Score for NRC is 45/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
NRC reports a high gross margin of 63.1% (sector average: 46.3%) and a solid operating margin of 17.1%.
NRC shows revenue declining at 4% year-over-year, with earnings declining at 54%.
NRC pays a modest dividend yield of 2.8%.